• News
  • Movies
  • Money
  • Health
  • Videos
More
  • Health News
  • Features
  • Food
  • Wellness
  • Diseases
  • Pregnancy
  • Parenting
  • Mental Health
  • Stress

Amid COVID, kids in Kerala suffer disease similar to Kawasaki

# Shinila Manthottathil
Dec 6, 2020, 09:04 AM IST
T- T T+
MIS-C
Caption

Kozhikode: Amid the growing concern of COVID-19, another disease which largely affects kids is also reported in Kerala. The disease called Multisystem Inflammatory Syndrome (MIS-C) has similar symptoms of Kawasaki disease reported in Japan in 1971.

If not treated on time, this syndrome will damage the heart muscles.

Till date, 15 children with symptoms of MIS-C sought medical care at Baby Memorial hospital in Kozhikode. Among them, three were in critical condition. Over 10 MIS-C cases were reported in Thiruvananthapuram medical college. The disease was also reported in Kozhikode medical college and hospitals in Kochi.

According to reports, MIS-C was confirmed within 2 months after COVID-19 outbreak in Europe and the US.

The first case in Asia was reported from Kozhikode at the end of April. Later, the disease was confirmed in many parts of the country.

Treatable if detected on time

According to experts, MIS-C can be treated if detected on time. Those who test negative for COVID-19 should not neglect the symptoms. They should immediately seek medical care.

Antibody test will be conducted to confirm whether they contracted coronavirus infection. Treatment will start after the test.

Symptoms of MIS-C

  • Redness on eyes and mouth
  • Persistent fever
  • Rashes on body
  • Redness and swelling on hands and feet
  • Strong stomach ache and diarrhoea

What is MIS-C?

MIS-C is found as an excessive immune response associated with COVID-19. Usually, this syndrome will turn severe only among 5 percent patients. If MIS-C turns severe, it will result in myocarditis which affects the heart muscles.

Lungs, kidney, digestive system, brain, skin, eyes and blood vessels will also get damaged as a result of the disease.

In rare cases, death is also reported.

Treatment

IV Immunoglobulin infusion and steroid are used to treat MIS-C patients.

“MIS-C is confirmed in places of Kerala where COVID-19 spread is found to be critical. This disease is largely found among patients within one or two months after testing COVID-19 positive. In 2010, MIS-C was confirmed in many people who were diagnosed with H1N1 disease. But compared to H1N1, this disease is largely found associated with COVID-19 infection. In the present circumstances, more children are likely to get affected by the disease,” said Dr Ajay V, Paediatric critical care specialist at Baby Memorial hospital in Kozhikode.

 

 

 

 

PRINT
EMAIL
COMMENT
 
 
 
  • Tags :
    • MIS-C
    • Coronavrirus
More from this section
Randeep Guleria
Hopeful India will get Covid-19 vaccine nod by December end or early January: AIIMS Director
Pfizer
Who, when and how? A look at the UK's vaccination rollout
Pfizer
UK approves Pfizer-BioNTech vaccine; to be made available from next week
covid vaccine
'Covidshield' vaccine trial participant alleges neuro breakdown, impaired cognitive functions
covid vaccine
EU official: 2 vaccines could be authorized soon
News in Videos
News+ Kerala India NRI World Columns Features Offbeat Good News Crime
Leisure Movies & Music Sports Travel Books
Learn Money Education Agriculture
Lifestyle Health Tech Food Astrology
Multimedia Gallery Videos Mojo News News In Pics
Our Network Malayalam Print Mathrubhumi News TV Kappa TV Club FM Seed Silver Bullet FindHome Media School MBIFL Redmic
E-Paper
Subscription
Buy Books
Magazines
Classifieds
Archives
 
  • E-Paper
  • Subscription
  • Buy Books
  • Magazines
  • Classifieds
  • Archives
© Copyright Mathrubhumi 2020. All rights reserved.
About Us Contact Us Privacy Policy
Terms of Use Archives
Ad Tariff Download App Classifieds
Buy Books Subscription e-Subscription
 
           
© Copyright Mathrubhumi 2020. All rights reserved.